1.	Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy Phase: Phase III Type: Supportive care, Tissue collection/Repository Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000684240, NCCTG-N08C9, N08C9, NCT01198145
2.	Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Active Age: 6 months to 21 years Sponsor: NCI, Other Protocol IDs: CDR0000695661, COG-ACCL0934, ACCL0934, NCT01371656
3.	Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy Phase: Phase III Type: Supportive care, Tissue collection/Repository, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000716291, NCCTG-N10CB, N10CB, NCT01473290
4.	Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 4P-11-3, NCI-2011-03266, NCT01469338
5.	Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: VAR0084, NCI-2012-01127, NCT01644097